Results 101 to 110 of about 20,254 (207)
Effectiveness of alteplase in the very elderly after acute ischemic stroke
Josef Yayan Department of Internal Medicine, University Hospital of Saarland, Homburg/Saar, Germany Abstract: Alteplase has traditionally been the only pharmacologic agent available for treating acute ischemic stroke worldwide, and is considered an ...
Yayan J
doaj
Background: Tenecteplase (TNK) is a novel thrombolytic agent gaining attention as an alternative to alteplase for treating acute ischemic stroke (AIS).
Muhammad Hassan Waseem +9 more
doaj +1 more source
Uso de trombolíticos e associações farmacológicas no tratamento do acidente vascular cerebral isquêmico agudo : revisão sistemática e meta-análise em rede [PDF]
Dissertação (mestrado)—Universidade de Brasília, Faculdade de Ciências da Saúde, Programa de Pós-Graduação em Ciências da Saúde, 2017.Introdução: O acidente vascular cerebral isquêmico (AVCi) é uma das principais causas de mortalidade e incapacidade ...
Brito, Gabriela Vilela de
core
Timing of vessel imaging for suspected large vessel occlusions does not affect groin puncture time in transfer patients with stroke. [PDF]
BACKGROUND: Access to endovascular therapy (ET) in cases of acute ischemic stroke may be limited, and rapid transfer of eligible patients to hospitals with endovascular capability is needed.
Dhamoon, Mandip S. +5 more
core +1 more source
Evaluating the Safety of Tenecteplase Versus Alteplase for Acute Ischemic Stroke
Background/Objectives: This study aims to compare the safety of tenecteplase versus alteplase for acute ischemic stroke. Methods: This was a multicenter, retrospective cohort study including 11 Memorial Hermann Health System hospitals in Houston from 7 ...
Salma Guerrero Miranda +4 more
doaj +1 more source
Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke [PDF]
Background: Orolingual angioedema can occur during thrombolysis with alteplase in stroke patients. However, data about its frequency, severity and the significance of concurrent use of angiotensin-converting-enzyme inhibitors (ACEi) are sparse. Objective:
Buitrago-Téllez, C. +6 more
core
Background Stroke was the second leading cause of death and the third leading cause of disability worldwide in 2019. Alteplase is an FDA-approved medication for the treatment of patients with ischemic stroke within 4.5 h.
Abdelmonam M. Hagag +9 more
doaj +1 more source
Implementation of a Tenecteplase Protocol for Treatment of Acute Ischemic Stroke in a Health System
Purpose. Alteplase is the standard of care for intravenous thrombolytic treatment of acute ischemic stroke, but recent evidence suggests that tenecteplase may be as safe and efficacious. The purpose of this study was to evaluate the direct cost savings,
Alexis Pace, Maya Wai, Ethan Frye
doaj
The use of thrombolytics in the management of complex pleural fluid collections [PDF]
Bahjri, Khaled +6 more
core +2 more sources

